AIM ImmunoTech Inc. (AIM)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$88,000$170,000$202,000$141,000$135,000$163,000$140,000$367,000$437,000$92,000$133,000$197,000$150,000$213,000$161,000$135,000$111,000
Research & development$3.9M$6.2M$10.9M$7.0M$7.7M$5.7M$4.7M$4.8M$4.1M$5.1M$8.0M$9.0M$8.4M$9.5M$6.7M$7.6M$7.0M
Operating income−$11.7M−$19.8M−$31.9M−$19.9M−$18.8M−$15.2M−$12.4M−$11.5M−$11.4M−$13.8M−$16.6M−$19.1M−$17.2M−$20.3M−$14.3M−$16.4M−$13.3M
EBITDAderived−$11.5M−$19.5M−$31.7M−$19.7M−$18.1M−$14.4M−$11.7M−$10.6M−$10.4M−$12.6M−$15.7M−$18.4M−$16.3M
Net income−$14.0M−$17.3M−$29.0M−$19.4M−$19.1M−$14.4M−$9.4M−$9.8M−$8.3M−$7.5M−$15.2M−$17.4M−$16.2M−$17.4M−$9.0M−$13.1M−$7.2M
Basic EPSper diluted share-$8.62-$30.92-$0.60-$0.40-$0.40-$0.45-$2.58-$9.77-$0.29-$0.34-$0.77-$1.11-$0.10-$0.12-$0.07-$0.10-$0.07
Diluted EPSper diluted share-$8.62-$30.92-$0.60-$0.40-$0.40-$0.45-$2.58-$9.77-$0.29-$0.34-$0.77-$1.11-$0.10-$0.12-$0.07-$0.10-$0.07

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys19$212.4K disclosed value
Sells (SEC code S)1$870.20 disclosed value
20 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 13, 2025Form 4Equels Thomas KCEO & PresidentBuyCommon Stock107$7.70$823.9038.9K
Jun 12, 2025Form 4Equels Thomas KCEO & PresidentBuyCommon Stock103$8.70$896.1038.7K
Apr 11, 2025Form 4MITCHELL WILLIAM MDirectorBuyCommon Stock196.9K$0.03$5.9K521.7K
Apr 11, 2025Form 4Equels Thomas KCEO & PresidentBuyCommon Stock1.97M$0.03$59.1K3.87M
Apr 11, 2025Form 4KELLNER TED DDirectorBuyCommon Stock1.97M$0.03$59.1K1.97M